Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Bacterial Infections and Mycoses

Free Subscription 08.12.2025 1 Am J Respir Crit Care Med 1 Ann Intern Med 1 Biochemistry 1 Chemotherapy 1 Curr Microbiol 17 J Antimicrob Chemother 2 J Infect Dis 1 J Med Chem 1 JAMA 1 Nature 4 Pediatrics 2 PLoS Negl Trop Dis 4 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. XIAO K, Cao Y, Yan P, Hu Y, et al
   A Large-Scale Single-Cell Atlas Reveals the Peripheral Immune Panorama of Bacterial Pneumonia.
   Am J Respir Crit Care Med. 2025;211:2363-2381.
   PubMed         Abstract available
   
   

   
   Ann Intern Med

2. FREEDMAN DO
   Asheville, North Carolina: The Origin of the American Tuberculosis Sanitarium Movement.
   Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-02861.
   PubMed         Abstract available
   
   

   
   Biochemistry

3. HYATT BL, Rodrigo MKD, Barnett TC
   Impact of Host and Bacterial Metabolism on Antibiotic Susceptibility.
   Biochemistry. 2025;64:4555-4564.
   PubMed         Abstract available
   
   

   
   Chemotherapy

4. GATTI M, Cojutti PG, Pea F
   Role of a Therapeutic Drug Monitoring-Guided Strategy of Isavuconazole for Optimizing Efficacy/Safety Outcomes in Onco-Hematological Pediatric Patients: A Systematic Review.
   Chemotherapy. 2025;70:163-176.
   PubMed         Abstract available
   
   

   
   Curr Microbiol

5. SINGH S, Dubal ZB, Kumar GR, Tamta S, et al
   Genomic Constellation of Foodborne Proteus Mirabilis Isolates Harboring AMR, Virulence Genes and Comparative WGS Analysis.
   Curr Microbiol. 2025;83:54.
   PubMed         Abstract available
   
   

   
   J Antimicrob Chemother

6. BALTAS I, Tsakri D, Vourli S, Solanki H, et al
   Comparative evaluation of disc diffusion and broth microdilution methods for aztreonam/avibactam susceptibility testing in Enterobacterales.
   J Antimicrob Chemother. 2025;80:3273-3277.
   PubMed         Abstract available
   
   
7. MA J, van Doodewaerd BR, Biersack B, Verbon A, et al
   A drug-repurposing screen of FDA- and EMA-approved drugs identifies two NF-kappaB inhibitors active against eumycetoma.
   J Antimicrob Chemother. 2025;80:3320-3328.
   PubMed         Abstract available
   
   
8. BLANCO-MARTIN T, Guzman-Puche J, Hernandez-Garcia M, Munoz-Rosa M, et al
   Mechanisms of resistance to ceftazidime/avibactam in mutants derived in vitro from Klebsiella pneumoniae producing OXA-48-like enzymes.
   J Antimicrob Chemother. 2025;80:3265-3272.
   PubMed         Abstract available
   
   
9. IACHKINE J, Alexandre K, Marlat C, Briant A, et al
   Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: a multicentre retrospective matched cohort study.
   J Antimicrob Chemother. 2025 Sep 30:dkaf370. doi: 10.1093.
   PubMed         Abstract available
   
   
10. CINCOTTA SE, Ostrowsky BE, Howard-Anderson J, Beekmann SE, et al
    Treatment preferences by infectious diseases clinicians for carbapenem-resistant Enterobacterales infections.
    J Antimicrob Chemother. 2025 Sep 30:dkaf371. doi: 10.1093.
    PubMed         Abstract available
    
    
11. LAI CC, Liu CY, Huang KJ, Huang YT, et al
    Global susceptibility profiles and potential resistance mechanisms of ceftazidime-avibactam-resistant, non-carbapenemase-producing carbapenem-resistant Enterobacterales: 2020-23 data from the Antimicrobial Testing Leadership and Surveillance.
    J Antimicrob Chemother. 2025 Oct 7:dkaf375. doi: 10.1093.
    PubMed         Abstract available
    
    
12. PELLEGRINO C, Veronese N, De Santis L, Amendolara A, et al
    Frailty Index Laboratory (FI-Lab) as predictor of poor outcomes for intra-hospital multidrug-resistant Klebsiella pneumoniae bloodstream infections: a single-centre retrospective cohort study.
    J Antimicrob Chemother. 2025;80:3257-3264.
    PubMed         Abstract available
    
    
13. SMITH S, Reilly CW, Stewart J, Ragh T, et al
    Thrice-weekly post-haemodialysis ceftazidime can achieve adequate pre-dialysis concentrations and clinical cure in patients with melioidosis.
    J Antimicrob Chemother. 2025;80:3386-3390.
    PubMed         Abstract available
    
    
14. MULLER SE, Junker S, Rehner J, Forster M, et al
    Comparative in vitro activity of ceftazidime-avibactam plus aztreonam and the fixed combination aztreonam/avibactam against multidrug-resistant Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2025;80:3352-3356.
    PubMed         Abstract available
    
    
15. ORENBUCH-HARROCH E, Snoyman G, Nashashibi MA, Temper V, et al
    Aztreonam-amoxicillin/clavulanate combination therapy against blaNDM-producing Enterobacterales infections.
    J Antimicrob Chemother. 2025;80:3375-3380.
    PubMed         Abstract available
    
    
16. VAN RHIJN N, White PL
    Antifungal treatment strategies and their impact on resistance development in clinical settings.
    J Antimicrob Chemother. 2025;80:3208-3226.
    PubMed         Abstract available
    
    
17. ZHANG H, Liang B, Tan Z, Wang R, et al
    The synergistic activity of tigecycline-based combinations against multidrug-resistant Acinetobacter baumannii-caused bloodstream infections.
    J Antimicrob Chemother. 2025;80:3407-3418.
    PubMed         Abstract available
    
    
18. NEOH CF, Yong MK, Rowley L, Roberts AW, et al
    Antifungal prophylaxis in patients with FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD)-positive acute myeloid leukaemia receiving sorafenib during initial induction and consolidation treatment in ALLG AMLM16 trial.
    J Antimicrob Chemother. 2025;80:3401-3406.
    PubMed         Abstract available
    
    
19. FU Y, Fouad A, Roenfanz HF, Nicolau DP, et al
    Efficacy of human-simulated aztreonam-avibactam against Stenotrophomonas maltophilia in the neutropenic murine thigh infection model.
    J Antimicrob Chemother. 2025;80:3431-3437.
    PubMed         Abstract available
    
    
20. REZZOUG I, Ouacel K, Droit T, Ronsin S, et al
    Therapeutic challenges in treating ESBL- and/or AmpC-producing non-carbapenemase-producing Enterobacterales: an in vitro evaluation of novel beta-lactam/beta-lactamase inhibitor combinations and cefiderocol.
    J Antimicrob Chemother. 2025;80:3297-3305.
    PubMed         Abstract available
    
    
21. PALACIOS R, Gomez-Ayerbe C, Martin-Cortes S, Gonzalez-Jimenez A, et al
    Post-exposure prophylaxis with doxycycline (DoxyPEP) to prevent STIs in a real-world setting: the PRIDOX study.
    J Antimicrob Chemother. 2025;80:3306-3310.
    PubMed         Abstract available
    
    
22. CANAS MA, Cuervo G, Garcia-Gonzalez J, Krivak F, et al
    In vitro exebacase (CF-301) activity against methicillin-susceptible or methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci strains isolated from patients with infective endocarditis.
    J Antimicrob Chemother. 2025 Dec 4:dkaf435. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect Dis

23. BUNJUN R, Lurie M, Dabee S, Barnabas S, et al
    Chlamydia trachomatis-specific T Cell Immunity Reflects Widespread Exposure in South African Adolescents and Young Women.
    J Infect Dis. 2025 Dec 3:jiaf595. doi: 10.1093.
    PubMed         Abstract available
    
    
24. JANSSEN NAF, Bruno M, Berk Y, Reijers MHE, et al
    Interferon-gamma production defects characterise immune responses in patients with chronic pulmonary aspergillosis.
    J Infect Dis. 2025 Nov 29:jiaf596. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Chem

25. KUMAR TA, Birua S, Mallojjala SC, Mukherjee P, et al
    A Mycobacteria-Specific Prodrug to Overcome Phenotypic AMR in Mycobacterium tuberculosis.
    J Med Chem. 2025 Dec 1. doi: 10.1021/acs.jmedchem.5c01848.
    PubMed         Abstract available
    
    

    
    JAMA

26. CHEVALIER FJ, Bacon O, Johnson KA, Cohen SE, et al
    Syphilis: A Review.
    JAMA. 2025 Oct 16. doi: 10.1001/jama.2025.17362.
    PubMed         Abstract available
    
    

    
    Nature

27. LUCHETTI G, Miner MV, Peterson RM, Scott WP, et al
    Enteropathogenic bacteria evade ROCK-driven epithelial cell extrusion.
    Nature. 2025;648:166-172.
    PubMed         Abstract available
    
    

    
    Pediatrics

28. LIU J, Chow T
    Diagnosing Paediatric Mild Acute Food Protein-Induced Enterocolitis Syndrome: Proposal of New Criteria.
    Pediatrics. 2025;156.
    PubMed        
    
    
29. LE T, Gupta M
    The Prevalence of Peanut-Triggered Food Protein-Induced Enterocolitis Syndrome in a Prospective Cohort of Infants Introducing Peanut in the First Year of Life.
    Pediatrics. 2025;156.
    PubMed        
    
    
30. SANDERS JM, Shaker MS
    Oral Food Challenge Protocols in Food Protein-Induced Enterocolitis Syndrome: A Systematic Review.
    Pediatrics. 2025;156.
    PubMed        
    
    
31. KAMDAR S, Sicherer SH
    Resolution of Food Protein-Induced Enterocolitis Syndrome-A Long-Term Follow-Up Study of 113 Swedish Children.
    Pediatrics. 2025;156.
    PubMed        
    
    

    
    PLoS Negl Trop Dis

32. LE TURNIER P, Oberlis M, Lavergne A, Epelboin L, et al
    Leptospirosis seroprevalence and exposure factors in three informal settlements of French Guiana: An opportunistic survey.
    PLoS Negl Trop Dis. 2025;19:e0013764.
    PubMed         Abstract available
    
    
33. RASOLOFOZAFY H, Ronse M, Andrianiriana LMJ, Andriamira R, et al
    Leprosy perceptions and health seeking behaviour in Miandrivazo district, Madagascar.
    PLoS Negl Trop Dis. 2025;19:e0013212.
    PubMed         Abstract available
    
    

    
    PLoS One

34. MARGINEANU I, Gafar F, Butnaru T, Baiceanu D, et al
    Factors influencing drug-susceptible tuberculosis treatment outcomes in Romania and Ukraine.
    PLoS One. 2025;20:e0337937.
    PubMed         Abstract available
    
    
35. ESMAEL A, Mihret A, Abebe T, Mussa D, et al
    Correction: Activation and proliferation profiles of M.tuberculosis specific dual functional CD4+T cells from smear negative pulmonary TB patients.
    PLoS One. 2025;20:e0338017.
    PubMed         Abstract available
    
    
36. NGWIRA A, Manda SOM, Karimuribo ED, Kimera SI, et al
    JSTMapp: A web-based joint spatiotemporal modelling and mapping application for epidemiologists.
    PLoS One. 2025;20:e0332607.
    PubMed         Abstract available
    
    
37. 
    Retraction: Investigating the association between Candida albicans and early childhood dental caries: A comprehensive systematic review and meta-analysis.
    PLoS One. 2025;20:e0337750.
    PubMed        
    
    

    
    PLoS Pathog

38. MOTTA C, Turley M, Barbieri G, Fama A, et al
    A single amino acid substitution in Fibronectin Binding protein A (FnBPA) governs Staphylococcus aureus virulence via host transglutaminase-mediated fibrin crosslinking.
    PLoS Pathog. 2025;21:e1013743.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

39. ESTEVES NC, Tao R, Pu Q, Banerjee A, et al
    Nitric oxide promotes rapid development of motility to accelerate biofilm dispersal in Vibrio cholerae.
    Proc Natl Acad Sci U S A. 2025;122:e2526864122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.